Financial Year |
March 31 2023 |
Monetary Funds |
477,014,480.12 |
Held-for-trading Financial Assets |
1,225,825.66 |
Notes Receivable |
1,755,000.00 |
Accounts Receivable |
1,093,986,284.81 |
Advances to Suppliers |
31,570,397.19 |
Other Receivables |
8,424,354.82 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,968,091,954.29 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
87,504,387.89 |
Total Current Assets |
3,759,164,991.35 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
59,911,624.72 |
Fixed Assetes |
1,086,573,514.53 |
Under-construction Projects |
201,488,789.93 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
294,914,270.60 |
R&D expenses |
-- |
Goodwill |
372,987,552.49 |
Long-Term Deferred and Prepaid Expenses |
386,863.40 |
Deferred Income Tax Assets |
191,337,957.55 |
Other Non-Current Assets |
18,693,130.47 |
Sub-Total of Non-Current Assets |
2,238,248,107.26 |
Total Assets |
5,997,413,098.61 |
Short-Term Loans |
450,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
614,942,079.64 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
166,616,649.97 |
Taxes Payable |
73,908,054.66 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
44,781,167.82 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,773,094.24 |
Other Current Liabilities |
402,482.86 |
Sub-Total of Current Liabilities |
1,356,521,935.41 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
54,633,752.84 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
241,554,487.37 |
Total Liabilities |
1,598,076,422.78 |
Paid-In Capital(Or Share Stock) |
941,740,157.00 |
Capital Surplus |
381,312,282.19 |
Surplus Reserve |
375,823,827.76 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
2,689,061,226.46 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,399,336,675.83 |
Owner's Equity(Stockholder's Equity) |
4,399,336,675.83 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,997,413,098.61 |